... found that SoloSTAR(R) required 31% less injection force than the Novo Nordisk FlexPen(R) and 54% less force than the Eli Lilly Humulin/Humalog pen. ...
Both studies are multi-center, open label and six months in duration, comparing the effects of VIAject to Humulin R, the leading recombinant human insulin. ...
A severe hypoglycemic, I took my regular 5 units of R Humulin 30 minutes before lunch. Instead of my normal sandwich and milk at lunch, I drank a glass of ...
Both studies are multi-center, open label and six months in duration, comparing the effects of VIAject(TM) to Humulin(R) R, the leading recombinant human ...
Both studies are multi-center, open label and six months in duration, comparing the effects of VIAject(TM) to Humulin(R) R, the leading recombinant human ...
... statistically significant and clinically relevant improved glycemic control compared to regular human insulin (Humulin(R) R) and lispro (Humalog(R)). ...
VIAject(TM) is currently being tested in two pivotal Phase III clinical trials, which are comparing the effects of VIAject(TM) to Humulin(R) R, ...
... and the other enrolling 400 patients with Type 2 diabetes, are comparing the effects of VIAject and Humulin R, the leading recombinant human insulin. ...
... and the other enrolling 400 Type 2 diabetic patients, are comparing the effects of VIAject(TM) to Humulin(R) R, the leading recombinant human insulin. ...
... “We are pleased that VIAject continues to yield improved pharmacokinetic and pharmacodynamic data when compared to both Humulin R and Humalog. ...